Skip to content
← Holders

Tetragon Partners GP Ltd

What Tetragon Partners GP Ltd reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1515070 · Filed Nov 16, 2026

Positions
37
Reported value
$766M
Opened
6
Closed
8
Other managers included
3

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$747.6M
    44 positions
  2. Dec 31, 2025$474.3M
    28 positions
  3. Mar 31, 2026$515.1M
    36 positions
  4. Jun 30, 2026$635.1M
    39 positions
  5. Sep 30, 2026$766M
    37 positions
SecuritySharesChangeValueOf portfolio
PATHUiPath, Inc.
32.5M+5.0%$417.3M54.5%
KGEIKolibri Global Energy Inc.
6.8M±0%$42.3M5.5%
SLNSilence Therapeutics plc
2.4M+218.7%$26.6M3.5%
PHVSPharvaris N.V.
838.2K+183.5%$26.6M3.5%
IONSIonis Pharmaceuticals Inc
440.9K+353.8%$19.7M2.6%
AUTLAutolus Therapeutics plc
9.5M±0%$18.4M2.4%
ARWRArrowhead Pharmaceuticals, Inc.
264K+102.4%$17.3M2.3%
LYFTLyft, Inc.
1M±0%$15M2%
WKWorkiva Inc
225K−10.0%$15M2%
MBXMBX Biosciences, Inc.
220.6K+8.4%$12.9M1.7%
DFTXDefinium Therapeutics, Inc.
310.9K+8.3%$11.8M1.5%
CXMSprinklr, Inc.
2.2M±0%$10.9M1.4%
CLDXCelldex Therapeutics, Inc.
295.9K+1.9%$9.6M1.3%
IMVTImmunovant, Inc.
275.2K+7.5%$9.3M1.2%
HRMYHarmony Biosciences Holdings, Inc.
226.7K+12.8%$8.9M1.2%
ALKTAlkami Technology, Inc.
650K+8.3%$8.9M1.2%
ALKSAlkermes plc.
206.8K+8.8%$8.4M1.1%
DYNDyne Therapeutics, Inc.
511.3K+43.4%$8.2M1.1%
RLAYRelay Therapeutics, Inc.
447.2K−21.6%$8.1M1.1%
AGIOAgios Pharmaceuticals, Inc.
215.5K+4.8%$7.2M0.9%
CELCCelcuity Inc.
87.4K+36.4%$7M0.9%
NBIXNeurocrine Biosciences Inc
47KNew$6.7M0.9%
KRYSKrystal Biotech, Inc.
19.7K±0%$6.5M0.9%
AXSMAxsome Therapeutics, Inc.
35KNew$6.5M0.8%
WBDWarner Bros. Discovery, Inc.
200K−20.0%$6.2M0.8%
NKTRNektar Therapeutics
101.6K+16.8%$6.2M0.8%
SLNSilence Therapeutics plcCall option
500K+66.7%$5.5M0.7%
UBERUber Technologies, Inc
71.4KNew$4.9M0.6%
SNOWSnowflake Inc.
10K±0%$3.4M0.4%
ANTXAN2 Therapeutics, Inc.
603.4KNew$3.2M0.4%
ANNXAnnexon, Inc.
655.9K−47.2%$2.8M0.4%
AGIOAgios Pharmaceuticals, Inc.Call option
50K±0%$1.7M0.2%
GLUEMonte Rosa Therapeutics, Inc.Call option
100KNew$1.2M0.2%
GLUEMonte Rosa Therapeutics, Inc.
56.1K±0%$668.7K0.1%
TECXTectonic Therapeutic, Inc.
26.8K−42.4%$624.1K0.1%
SLGLSol-Gel Technologies Ltd.
8.3KNew$617K0.1%
TENXTenax Therapeutics, Inc.Call option
75.1K±0%$141.9K0.1%